tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
MESO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsMESO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
Mesoblast gets years of orphan-drug exclusive approval from FDA for Ryoncil
Premium
The Fly
Mesoblast gets years of orphan-drug exclusive approval from FDA for Ryoncil
3M ago
Mesoblast extends payer coverage for Ryoncil to over 100M U.S. lives
Premium
The Fly
Mesoblast extends payer coverage for Ryoncil to over 100M U.S. lives
4M ago
Mesoblast’s Earnings Call: RYONCIL Approval & Growth
PremiumCompany AnnouncementsMesoblast’s Earnings Call: RYONCIL Approval & Growth
5M ago
Buy Rating for Mesoblast Driven by Promising Market Position and Strong Financial Backing
Premium
Ratings
Buy Rating for Mesoblast Driven by Promising Market Position and Strong Financial Backing
5M ago
Mesoblast Reports FDA Approval and Financial Results
Premium
Company Announcements
Mesoblast Reports FDA Approval and Financial Results
5M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
7M ago
Mesoblast Stock Rockets to New 52-Week High
Premium
Market News
Mesoblast Stock Rockets to New 52-Week High
7M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100